Comparison of the Hypoglycemic, Hypolipidemic and Hepatoprotective Effects of Asparagus racemosus Linn. in Combination with Gliclazide and Pioglitazone on Alloxan-Induced Diabetic Rats
In recent years, the popularity of medicinal plants as a remedy has been increased manifold due to having minimal adverse effects. The current study aimed to compare the hypoglycemic, hypolipidemic and hepatoprotective effects of the ethanolic extract of Asparagus racemosus (EEAR) Linn. alone and combinedly with conventional antidiabetic agents (gliclazide and pioglitazone) in alloxan-induced diabetic rats. Diabetes was induced in male Wister albino rats by the administration of single intra-peritoneal injection of alloxan monohydrate (120 mg/kg b.w.). Effect of oral administration of two different doses of EEAR (200 and 400 mg/kg b.w.), gliclazide (10 mg/kg b.w.) and pioglitazone (10 mg/70kg/b.w.) alone for 2 weeks and a combination of EEAR (200 mg/kg b.w.) with either gliclazide (10 mg/kg b.w.) or pioglitazone (10 mg/70kg/b.w.) for 2 weeks were examined on hypoglycemic activity on 0th, 5th, 10th and 14th day of treatment. After 2 weeks of treatment, hypolipidemic and hepatoprotective effects were estimated by serum biochemical markers such as total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL), very low density lipoprotein (VLDL), high density lipoprotein (HDL), serum glutamate oxaloacetate transaminases (SGOT), serum glutamate pyruvate trans-aminases (SGPT) and total protein (TP) with the help of commercially available kits. The survival rate, body weight and organ weight were also measured. Alloxan treatment resulted in persistent hyperglycemia, hyperlipidemia and liver dysfunction in rats. Treatment with EEAR at different doses improved hyperglycemia significantly (p < 0.05, p < 0.01, p < 0.001; p < 0.05, p < 0.01; p < 0.05) by reducing the blood glucose levels in rats on 10th and 14th day of treatment in a dose-dependent mood when compared to the disease control rats, gliclazide treated rats and pioglitazone treated rats. The combination therapy significantly (p < 0.001; p < 0.01, p < 0.001; p < 0.05, p < 0.01, p < 0.001) promoted the glucose-lowering activity on 5th, 10th and 14th day of treatment as compared to that of disease control rats, gliclazide treated rats and pioglitazone treated rats. Proposed adjunct therapy also markedly (p < 0.001; p < 0.01, p < 0.001) improved serum TG, HDL and LDL level with insignificant change in VLDL and TC level while comparing with groups receiving gliclazide treated rats and pioglitazone treated rats. Administration of different doses of
References
[1]
Venkatesh, S., Dayanand, R.G., Madhava, R.B., Ramesh, M. and Apparao, A.V.N. (2003) Antihyperglycemic Activity of Caralluma Attenuta. Fitoterapia, 74, 274-279.
https://doi.org/10.1016/S0367-326X(03)00021-2
[2]
Edwin, E., Sheeja, E., Dhanabal, S.P. and Suresh, B. (2007) Antihyperglycemic Activity of Passiflora Mollissima Bailey. Indian Journal of Pharmaceutical Sciences, 64, 570-571. https://doi.org/10.4103/0250-474X.36947
[3]
Lamb, R.E. and Goldstein, B.J. (2008) Modulating an Oxidative-Inflammatory Cascade: Potential New Treatment Strategy for Improving Glucose Metabolism, Insulin Resistance, and Vascular Function. International Journal of Clinical Practice, 62, 1087-1095. https://doi.org/10.1111/j.1742-1241.2008.01789.x
[4]
Johansen, J.S., Harris, A.K., Rychly, D.J. and Ergul, A. (2005) Oxidative Stress and the Use of Antioxidants in Diabetes: Linking Basic Science to Clinical Practice. Cardiovascular Diabetology, 4, 5. https://doi.org/10.1186/1475-2840-4-5
[5]
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012) Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 And 2010: A Systematic Analysis for the Global Burden of Disease Study 2010. The Lancet, 380, 2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0
[6]
Murray, C.J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., et al. (2012) Disability-Adjusted Life Years (DALYs) for 291 Diseases and Injuries in 21 Regions, 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. The Lancet, 380, 2197-2223. https://doi.org/10.1016/S0140-6736(12)61689-4
[7]
International Diabetes Federation (IDF) (2012) Country Estimates Table 2011. IDF Diabetes Atlas. http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf
[8]
Rahim, M.A., Hussain, A., Azad Khan, A.K., Sayeed, M.A., Keramat Ali, S.M. and Vaaler, S. (2007) Rising Prevalence of Type 2 Diabetes in Rural Bangladesh: A Population Based Study. Diabetes Research and Clinical Practice, 77, 300-305.
https://doi.org/10.1016/j.diabres.2006.11.010
[9]
Saquib, N., Saquib, J., Ahmed, T., Khanam, M.A. and Cullen, M.R. (2012) Cardiovascular Diseases and Type 2 Diabetes in Bangladesh: A Systematic Review and Meta-Analysis of Studies between 1995 and 2010. BMC Public Health, 12, 434.
https://doi.org/10.1186/1471-2458-12-434
[10]
Shera, A.S., Rafique, G., Khawaja, I.A., Baqai, S. and King, H. (1999) Pakistan National Diabetes Survey: Prevalence of Glucose Intolerance and Associated Factors in Baluchistan Province. Diabetes Research and Clinical Practice, 44, 49-58.
https://doi.org/10.1016/S0168-8227(99)00017-0
[11]
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., et al. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 1090-1101. https://doi.org/10.1056/NEJMoa0908292
[12]
Zhang, H., Xu, W., Dahl, A.K., Xu, Z., Wang, H.X. and Qi, X. (2013) Relation of Socio-Economic Status to Impaired Fasting Glucose and Type 2 Diabetes: Findings Based on a Large Population-Based Cross-Sectional Study in Tianjin, China. Diabetic Medicine, 30, e157-e162. https://doi.org/10.1111/dme.12156
[13]
Wild, S., Roglic, G. and Green, A. (2004) Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030. Diabetes Care, 27, 1047-1053.
https://doi.org/10.2337/diacare.27.5.1047
[14]
American Diabetes Association (2003) Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care, 26, 533-550.
[15]
International Diabetes Federation (2006) International Diabetes Federation Diabetes Atlas. Brussels.
[16]
Negrato, C.A., Dias, J.P. and Teixeira, M.F. (2010) Temporal Trends in Incidence of Type 1 Diabetes between 1986 and 2006 in Brazil. Journal of Endocrinological Investigation, 33, 373-377. https://doi.org/10.1007/BF03346606
[17]
Watts, G.F. and Playford, D.A. (1998) Dyslipoproteinaemia and Hyperoxidative Stress in the Pathogenesis of Endothelial Dysfunction in Non-Insulin Dependent Diabetes Mellitus: A Hypothesis. Atherosclerosis, 141, 17-30.
https://doi.org/10.1016/S0021-9150(98)00170-1
[18]
Wilson, P.W., D’Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H. and Kannel, W.B. (1998) Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation, 97, 1837-1847. https://doi.org/10.1161/01.CIR.97.18.1837
[19]
Wilson, P.W. (1998) Diabetes Mellitus and Coronary Heart Disease. American Journal of Kidney Diseases, 32, S89-S100.
https://doi.org/10.1053/ajkd.1998.v32.pm9820468
[20]
McGill, H.C. and McMahan, C.A. (1998) Determinants of Atherosclerosis in the Young: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. American Journal of Cardiology, 82, T30-T36.
https://doi.org/10.1016/s0002-9149(98)00720-6
[21]
Brezinka, V. and Padmos, I. (1994) Coronary Heart Disease Risk Factors in Women. European Heart Journal, 15, 1571-1584.
[22]
Geiss, L.S., Herman, W.H. and Smith, P.J. (1995) Mortality in Non-Insulin-Dependent Diabetes. In: National Diabetes Data Group, Eds., Diabetes in America, 2nd Edition, US Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Washington DC, 233-257.
[23]
Bosi, E. (2009) Metformin—The Gold Standard in Type 2 Diabetes: What Does the Evidence Tell Us? Diabetes, Obesity and Metabolism, 11, 3-8.
https://doi.org/10.1111/j.1463-1326.2008.01031.x
[24]
Noor, B., Rahman, J.A.M.S. and Hossain, K. (2010) Effects of Some Selected Factors on Blood Glucose Level of the Diabetic Patients: Evidence from Rajshahi City of Bangladesh. Journal of Scientific Research, 2, 67-76.
[25]
Hossain, M.M.S., Khan, M.R.I., Anisuzzaman, A.S.M., Ahmed, M., Amran, M.S. and Islam, A. (2011) Antidiabetic and Glycogenesis Effects of Different Fractions of Ethanolic Extract of Leaves of Mangifera indica (Linn.) in Normal and Alloxan Induced Diabetic Rats. Journal of Medical Science, 10, 80-86.
[26]
Malviya, N., Jain, S. and Malvia, S. (2010) Antidiabetic Potential of Medicinal Plants. Acta Poloniae Pharmaceutica. Drug Research, 67, 113-118.
[27]
Matafome, P., Louro, T., Rodriques, L., Crisostomo, J., Nunes, E., Amaral, C., et al. (2011) Metformin and Atorvastatin Combination Further Protect the Liver in Type 2 Diabetes with Hyperlipidaemia. Diabetes & Metabolism, 27, 54-62.
https://doi.org/10.1002/dmrr.1157
[28]
Matafome, P., Louro, T., Rodriques, L., Crisostomo, J., Nunes, E., Amaral, C., et al. (2011) Metformin and Atorvastatin Combination Further Protect the Liver in Type 2 Diabetes with Hyperlipidaemia. Diabetes/Metabolism Research and Reviews, 27, 54-62. https://doi.org/10.1002/dmrr.1157
[29]
Pieroni, A., Nebel, S., Quave, C., Munz, H. and Heinrich, M. (2002) Ethnopharmacology of Tiakra: Traditional Weedy Vegetables of the Arbereshe of the Vulture Area in Southern Italy. Journal of Ethnopharmacology, 81, 165-185.
https://doi.org/10.1016/S0378-8741(02)00052-1
[30]
Hannan, J.M.A., Marenah, L. and Ali, L. (2007) Insulin Secretory Actions of Extracts of Asparagus racemosus Root in Perfused Pancreas, Isolated Islets and Clonal Pancreatic β-Cells. Journal of Endocrinology, 192, 159-168.
https://doi.org/10.1677/joe.1.07084
[31]
Bopana, N. and Saxena, S. (2007) Asparagus racemosus—Ethanopharmacological Evaluation and Concervation Needs. Journal of Ethnopharmacology, 110, 1-15.
https://doi.org/10.1016/j.jep.2007.01.001
[32]
Jayashree, G.V., Rachitha, P., Krupashree, K., Kumar, K.H. and Khanum, F. (2013) Phytochemical Analysis of Methanolic Extract of Roots of Asparagus racemosus (Shatavari). International Journal of Pharma and Bio Sciences, 4, 250-254.
[33]
Shao, Y., Chin, C.K. and Ho, C.T. (1996) Anti-Tumour Activity of the Crude Saponins Obtained from Asparagus. Cancer Letters, 104, 31-36.
https://doi.org/10.1016/0304-3835(96)04233-4
[34]
Shimoyamada, M., Suzuki, M. and Sonta, H. (1990) Antifungal Activity of the Saponin Fraction Obtained from Asparagus and Its Active Principle. Agricultural and Biological Chemistry, 54, 2553-2557.
[35]
Edenharder, R. (1990) Antimutagenic Activity of Vegetable and Fruit Extracts against In-Vitro Benzo(A)Pyrene. Zeitschrift für die Gesamte Hygiene und Ihre Grenzgebiete, 36, 144-148.
[36]
Thatte, U.M. and Dahanukar, S.A. (1988) Comparative Study of Immunomodulating Activity of Indian Medicinal Plants, Lithium Carbonate and Glucan. Methods and Findings in Experimental and Clinical Pharmacology, 10, 639-644.
[37]
Rege, N.N., Nazarreth, H.M. and Isaac, A. (1989) Immunotherapeutic Modulation of Intraperitoneal Adhesions by A. racemosus. Journal of Postgraduate Medicine, 35, 199-203.
[38]
Dhuley, J.N. (1997) Effect of Some Indian Herbs on Macrophage Functions in Ochratoxin A Treated Mice. Journal of Ethnopharmacology, 58, 15-20.
https://doi.org/10.1016/S0378-8741(97)00072-X
[39]
Balansard, S. and Rayband, M. (1987) Diuretic Action of A. racemosus. Critical Reviews in Society of Biology, 126, 954-956.
[40]
Mamun, A.A., Hossain, M., Ariful Islam, A., Zaman, S. and Uddin, M.S. (2016) Asparagus racemosus Linn. Potentiates the Hypolipidemic and Hepatoprotective Activity of Fenofibrate in Alloxan-Induced Diabetic Rats. Plant, 5, 1-12.
http://www.sciencepublishinggroup.com/journal/paperinfo?journalid=211&paperId=10017291
[41]
Uddin M.S., Asaduzzaman M., Mamun A.A., Iqbal M.A., Wahid F. and Rony R.K. (2016) Neuroprotective Activity of Asparagus racemosus Linn. against Ethanol-Induced Cognitive Impairment and Oxidative Stress in Rats Brain: Auspicious for Controlling the Risk of Alzheimer’s Disease. Journal of Alzheimer Disease & Parkinsonism, 6, 245. https://doi.org/10.4172/2161-0460.1000245
http://www.omicsonline.org/alzheimers-disease-parkinsonism-abstract.php?abstract_id=78731
[42]
Sekine, T., Fukasawa, N., Kashiwagi, Y., Murakoshi, I. and Ruangrungsi, N. (1994) A 9, 10-Di Hydro Phenanthrene from Asparagus racemosus. Phytochemistry, 44, 763-764. https://doi.org/10.1016/S0031-9422(96)00579-1
[43]
Sekine, T., Ikegami, F., Fukasawa, N., Kashiwagi, Y., Aizawa, T., Fujii, Y., et al. (1995) Structure and Relative Stereochemistry of An Ewpolycyclic Alkaloid, Asparagamine A, Showing Anti-Oxytocin Activity, Isolated from Asparagus racemosus. Journal of the Chemical Society Perkin Transactions, 4, 391-393.
https://doi.org/10.1039/p19950000391
[44]
Hayes, P.Y., Jahidin, A.H., Lehmann, R., Penman, K., Kitching, W. and DeVoss, J.J. (2006) Structural Revision of Shatavarins I and IV, The Major Components from the Roots of Asparagus racemosus. Tetrahedron Letters, 47, 6965-6969.
https://doi.org/10.1016/j.tetlet.2006.07.121
[45]
Shao, Y., Chin, C.K., Ho, C.T., Ma, W., Garrison, S.A. and Huang, M.T. (1996) Antitumour Activity of the Crude Saponins Obtained from Asparagus. Cancer Letters, 104, 31-36. https://doi.org/10.1016/0304-3835(96)04233-4
[46]
Gang, Z.Z., Li, L.Z. and Xian, L.X. (1997) Study on the Isolation, Purification and Antioxidation Properties of Polysaccharides from Spirulina Maxima. Acta Botanica Sinica, 39, 77-81.
[47]
Liu, J., Yeo, H.C., Doniger, S.J. and Ames, B.N. (1997) Assay of Aldehydes from Lipid Peroxidation: Gas Chromatography-Mass Spectrometry Compared to Thioabarbituric Acid. Analytical Biochemistry, 245, 161-166.
https://doi.org/10.1006/abio.1996.9990
[48]
Liu, S.X., Chen, Y., Zhou, M. and Wan, J. (1997) Protective Effect of the Polysaccharide Kreskin on Inhibition of Lipo-Polysaccharide-Induced Nitric Oxide Production in Macrophages Caused by Oxidized Low-Density Lipoprotein. International Journal of Medical Sciences, 25, 507-509.
[49]
Zeng, N., Meng, X. and Zhang Y. (1997) Studies on the Antioxidative Effect of Constituents of Herba epimedii (ESPS). China Journal of Chinese Materia Medica, 22, 46-48.
[50]
Rana, T.S., Singh, K.K. and Rao, R.R. (1994) Some Interesting Reports on Indigenous Herbal Remedies for Diabetes Mellitus from India. 4th International Congress Ethnobiology, 47, 17-12.
[51]
Akhtar, M.S. and Shah, M.V. (1993) Elemental Constituents of Antidiabetic Screening of a Folklore Medicinal Plant Prescription. International Journal of Occupational Medicine and Environmental Health, 2, 46.
[52]
Hannan, J.M.A., Ali, L., Khaleque, J., Akhter, M., Flatt, P.R. and Abdel-Wahab, Y.H.A. (2012) Antihyperglycaemic Activity of Asparagus Racemosus Roots Is Partly Mediated by Inhibition of Carbohydrate Digestion and Absorption, and Enhancement of Cellular Insulin Action. British Journal of Nutrition, 107, 1316-1317.
https://doi.org/10.1017/S0007114511004284
[53]
Mahammed, N.L., Jyothi, G., Chary, T.N., Reddy C.H.V. and Reddy, G.N. (2013) Antidiabetic and Antihyperlipidamic Activity of Ethanolic Extract of the Leaf of Asperagus racemosus on Streptozotocin Induced Diabetes Rats. International Journal of Pharmaceutical and Chemical Sciences, 2, 627-633.
[54]
Vadivelan, R., Dipanjan, M., Umasankar, P., Dhanabal, S.P., Satishkumar, M.N., Antony, S., et al. (2011) Hypoglycemic, Antioxidant and Hypolipidemic Activity of Asparagus racemosus on Streptozotocin-Induced Diabetic in Rats. Advances in Applied Science Research, 2, 179-185.
[55]
Dheeba, B., kumar, P.S., Kannan, M. and Saravana, K. (2012) Antidiabetic and Antihyperlipidemic Activities of Asparagus racemosus in Alloxan Induced Diabetic Rats. Journal of Pharmacy Research, 5, 2469-2472.
[56]
Organisation for Economic Cooperation and Development (2002) OECD Guidelines for the Testing of Chemicals: Acute Oral Toxicity—Acute Toxic Class Method. OECD, Paris. http://www.oecd-ilibrary.org/docserver/download/9742301e.pdf?ex
[57]
Sena, C.M., Louro, T., Matafome, P., Nunes, E., Monteiro, P. and Seica, R. (2009) Antioxidant and Vascular Effects of Gliclazide in Type 2 Diabetic Rats Fed High-Fat Diet. Physiological Research, 58, 203-209.
[58]
Ali, H., Rahman, A.F.M.T., Islam, S., Mamun, A., Zannah, S., Alam, A.H.M.K., et al. (2014) Combined Therapy of Pioglitazone and Atorvastatin Alleviate Diabetes in Rats More Effectively than That of Monotherapy. Pharmacology & Pharmacy, 5, 504-513. https://doi.org/10.4236/pp.2014.55060
[59]
National Research Council (2011) Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington DC.
[60]
Shah, N.A. and Khan, M.R. (2014) Antidiabetic Effect of Sida Cordata in Alloxan Induced Diabetic Rats. BioMed Research International, 2014, Article ID: 671294.
https://doi.org/10.1155/2014/671294
[61]
Orasanu, V. and Plutzky, J. (2009) The Pathologic Continuum of Diabetic Vascular Disease. Journal of the American College of Cardiology, 53, S35-S42.
https://doi.org/10.1016/j.jacc.2008.09.055
[62]
Kemp, T.M., Barr, E.L.M. and Zimmet, P.Z. (2005) Glucose, Lipid, and Blood Pressure Control in Australian Adults with Type 2 Diabetes: The 1999-2000 AusDiab. Diabetes Care, 28, 1490-1492. https://doi.org/10.2337/diacare.28.6.1490
[63]
Laing, S.P., Swerdlow, A.J. and Slater, S.D. (2003) Mortality from Heart Disease in a Cohort of 23,000 Patients with Insulin-Treated Diabetes. Diabetologia, 46, 760-765.
https://doi.org/10.1007/s00125-003-1116-6
[64]
Bierman, E.L., Amaral, J.A.P. and Balknap, B.H. (1975) Hyperlipidemia and Diabetes Mellitus. Diabetes, 25, 509-515.
[65]
Cohen, R.V., Schiavon, C.A., Pinheiro, J.S., Correa, J.L. and Rubino, F. (2007) Duodenal-Jejunal Bypass for the Treatment of Type 2 Diabetes in Patients with Body Mass Index of 22-34 kg/m2: A Report of 2 Cases. Surgery for Obesity and Related Diseases, 3, 195-197. https://doi.org/10.1016/j.soard.2007.01.009
[66]
Das, S. and Barman, S. (2012) Antidiabetic and Antihyperlipidemic Effects of Ethanolic Extract of Leaves of Punica granatum in Alloxan-Induced Non-Insulin-Dependent Diabetes Mellitus Albino Rats. Indian Journal of Pharmacology, 44, 219-224. https://doi.org/10.4103/0253-7613.93853
[67]
Vijayvargia, R., Kumar, M. and Gupta, S. (2000) Effect of Enicostemma littorale Blume on Alloxan-Induced Diabetes Mellitus in Rats. Indian Journal of Experimental Biology, 38, 781-784.
[68]
Jothi, G. and Brindha, P. (2014) Antidiabetic and Antihyperlipidemic Effect of Parmelia perlata. ach. in Alloxan Induced Diabetic Rats. International Journal of Pharmacy and Pharmaceutical Sciences, 6, 43-44.
[69]
Fourlanos, S., Perry, C., Stein, M.S., Stankovich, J. and Harrison, L.C. (2006) A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults. Diabetes Care, 29, 970-975. https://doi.org/10.2337/dc05-2101
[70]
Trivedi, N.A., Mazumdar, B., Bhatt, J.D. and Hemavathi, K.G. (2004) Effect of Shilajit on Blood Glucose and Lipid Profile in Alloxan-Induced Diabetic Rats. Indian Journal of Pharmacology, 36, 373-376.
[71]
Gupta, S., Sharma, S.B., Bansal, S.K. and Prabhu, K.M. (2009) Antihyperglycemic and Hypolipidemic Activity of Aqueous Extract of Cassia auriculata L. Leaves in Experimental Diabetes. Journal of Ethnopharmacology, 123, 499-503.
https://doi.org/10.1016/j.jep.2009.02.019
[72]
Brown, W.V. (1994) Lipoprotein Disorders in Diabetes Mellitus. Medical Clinics of North America, 87, 143-161. https://doi.org/10.1016/S0025-7125(16)30180-8
[73]
Stamler, I., Vaccaro, O., Neaton, J.D. and Wentworth, D. (1993) Diabetes, Other Risk Factors and 12-Yrs Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 15, 434-444.
https://doi.org/10.2337/diacare.16.2.434
[74]
Ghoul, J.E., Smiri, M., Ghrab, S., Boughattas, N.A. and Ben-Attia, M. (2012) Antihyperglycemic, Antihyperlipidemic and Antioxidant Activities of Traditional Aqueous Extract of Zygophyllum Album in Streptozotocin Diabetic Mice. Pathophysiology, 19, 35-42. https://doi.org/10.1016/j.pathophys.2011.12.001
[75]
Al-Shamaony, L., Al-Khazraji, S.M. and Twaij, H.A. (2004) Hypoglycaemic Effect of Artemisia Herba Alba. II. Effect of a Valuable Extract on Some Blood Parameters in Diabetic Animals. Journal of Ethnopharmacology, 43, 167-171.
https://doi.org/10.1016/0378-8741(94)90038-8
[76]
Loci, A.S., Shaabha, M., Khazraji, A.L., Husain, A. and Twaija, A. (1994) Hypoglycemic Effect of a Valuable Extract of Artemicisia Herb Alba II. Effect of a Valuable Extract on Some Blood Parameters in Diabetic Animals. Journal of Ethnopharmacology, 43, 167-171. https://doi.org/10.1016/0378-8741(94)90038-8
[77]
Agardh, C.D., Bjorgell, P. and Nilson, E.P. (1999) The Effect of Tolbutamide on Lipoproteins, and Lipoproteinlipase and Hormone Sensitive Lipase. Diabetes Research and Clinical Practice, 46, 99-108. https://doi.org/10.1016/S0168-8227(99)00088-1
[78]
Daisy, P. and Priya, C.E. (2010) Hypolipidemic and Renal Functionality Potentials of the Hexane Extract Fractions of Elephantopus scaber Linn. International Journal of Biomedical Science, 6, 241-245.
[79]
Pierre, W., Gildas, A.J.H., Ulrich, M.C., Modeste, W.-N., Benoit, N.T. and Albert, K. (2012) Hypoglycemic and Hypolipidemic Effects of Bersama engleriana Leaves in Nicotinamide/Streptozotocin-Induced Type 2 Diabetic Rats. BMC Complementary and Alternative Medicine, 12, 264. https://doi.org/10.1186/1472-6882-12-264
[80]
Agila, K.N. and kavitha R. (2012) Antidiabetic, Antihyperlipidaemic and Antioxidant Activity of Oxalis corniculata in Alloxan Induced Diabetic Mice. Journal of Natural Sciences Research, 2, 9-12.
[81]
Nelson, D.L. and Cox, M.M. (2005) Lehninger: Principles of Biochemistry. WH Freeman and Company, New York.
[82]
Kim, W.R., Flamm, S.L., Adrian, M., Bisceglie, D. and Bodenheimer, H.C. (2008) Serum Activity of Alanine Aminotransferase (ALT) as an Indicator of Health and Disease. Hepatology, 47, 1363-1365. https://doi.org/10.1002/hep.22109
[83]
Stanely, P., Prince, P.M. and Menon, V. (1999) Hypoglycemic and Other Related Actions of Tinospora cordiofolia Roots in Alloxan Induced Diabetic Rats. Journal of Ethnopharmacology, 70, 9-15. https://doi.org/10.1016/S0378-8741(99)00136-1
[84]
Toma, A., Makonnen, E., Mekonnen, Y., Debella, A. and Adisakwattana, S. (2015) Antidiabetic Activities of Aqueous Ethanol and N-Butanol Fraction of Moringa stenopetala Leaves in Streptozotocin-Induced Diabetic Rats. BMC Complementary and Alternative Medicine, 15, 242. https://doi.org/10.1186/s12906-015-0779-0
[85]
Mythilypriya, R., Shanthi, P. and Sachdanandam, P. (2007) Oral Acute and Subacute Toxicity Studies with Kalpaamrutha, a Modified Indigenous Prepraration on Rats. Health Science Journal, 53, 351-358. https://doi.org/10.1248/jhs.53.351
